Geron Corporation faces securities fraud class action lawsuit; contact The Gross Law.
A recent securities fraud class action lawsuit has been filed against Geron Corporation, alleging misleading statements and omissions by the company. Investors who purchased Geron Corporation securities between March 19, 2018, and September 26, 2018, are encouraged to contact The Gross Law Firm before May 12, 2025, to discuss their legal rights. The lawsuit alleges that Geron Corporation made false statements and failed to disclose key information about the efficacy of its sole drug candidate, imetelstat, which is being developed as a treatment for myelofibrosis.
The class action lawsuit alleges that Geron Corporation failed to disclose to investors that the drug imetelstat did not provide any meaningful benefit for patients with myelofibrosis. Instead, Geron Corporation allegedly misled investors by touting the drug’s potential efficacy while withholding crucial information about its limitations. As a result, investors who purchased Geron Corporation securities during the specified time period suffered significant financial losses when the truth about imetelstat’s efficacy was revealed.
Investors who purchased Geron Corporation securities during the class period may be eligible to recover their losses through participation in the securities fraud class action lawsuit. By contacting The Gross Law Firm before May 12, 2025, investors can learn more about their legal rights and options for seeking compensation for their losses. It is essential for affected investors to act promptly to ensure that they do not miss the deadline for filing a claim in the class action lawsuit against Geron Corporation.
Securities fraud class action lawsuits like the one against Geron Corporation are designed to hold companies accountable for misleading investors and causing financial harm. By participating in the class action lawsuit, investors can seek justice for the losses they have suffered due to the alleged securities fraud committed by Geron Corporation. It is crucial for affected investors to take action and explore their options for legal recourse to recover their losses and hold Geron Corporation accountable for its alleged misconduct.
If you are an investor who purchased Geron Corporation securities between March 19, 2018, and September 26, 2018, and suffered financial losses as a result of the alleged securities fraud, you are encouraged to contact The Gross Law Firm before May 12, 2025. The team of experienced attorneys at The Gross Law Firm can provide you with essential information about your legal rights and options for participating in the securities fraud class action lawsuit against Geron Corporation. Don’t delay – act now to protect your rights and seek compensation for the losses you have endured as a result of Geron Corporation’s alleged misconduct.
